BSX
$26.38
Boston Scientific
$.20
.76%
BSX
Earnings Whisper ®
N/A
2nd Quarter June 2017
Consensus:  $0.31
Revenue:  $2.21 Bil
Thursday
Jul 27
6:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when BSX reports earnings?
Beat
Meet
Miss

Where is BSX's stock price going from here?
Up
Flat
Down
Stock chart of BSX
Analysts
Summary of analysts' recommendations for BSX
Score
Grade
Pivots
Resistance
$27.08
$26.77
$26.58

$26.27

Support
$26.08
$25.77
$25.58
Tweet
Growth
Description
Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. The company's products are used in a broad range of interventional medical specialties, including cardiology, electrophysiology, gastroenterology, neuro-endovascular therapy, pulmonary medicine, radiology, urology and vascular surgery.
Peers
StrykerAbbott LaboratoriesIntegra LifeSciences HoldingsBecton, DickinsonC. R. BardWatersBaxter International3MResMedHaemonetics